SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth ...

A new study finds that gut-specific TM6SF2 depletion exacerbates liver fat accumulation and dysbiosis in mice on high-fat ...

Women who experience menopause before the age of 50 - and especially before the age of 45 - are more likely to develop fatty liver disease and its related metabolic risk factors within one year after ...

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...

Discover a study presented at EASL 2025 that found that timely public health policies can reduce the global burden of MASLD.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...

Women who experience menopause before the age of 50—and especially before the age of 45—are more likely to develop fatty liver disease and its related metabolic risk factors within one year after ...